Humana Inc. diskutieren
Humana Inc.
WKN: 856584 / Symbol: HUM / Name: Humana / Aktie / Anbieter & Dienstleistungen / Large Cap /
202,00 €
-2,86 %
Humana Inc. (NYSE: HUM) had its price target lowered by analysts at Wells Fargo & Company from $348.00 to $344.00. They now have an "overweight" rating on the stock.
Ratings data for HUM provided by MarketBeat
Humana (NYSE:HUM) had its price target raised by analysts at Royal Bank Of Canada from $283.00 to $322.00. They now have an "outperform" rating on the stock.
Ratings data for HUM provided by MarketBeat
Humana (NYSE:HUM) had its price target raised by analysts at Sanford C. Bernstein from $269.00 to $341.00. They now have an "outperform" rating on the stock.
Ratings data for HUM provided by MarketBeat
Humana (NYSE:HUM) had its "buy" rating reaffirmed by analysts at Guggenheim.
Ratings data for HUM provided by MarketBeat
Humana (NYSE:HUM) was given a new $347.00 price target on by analysts at Wells Fargo & Company. They now have an "overweight" rating on the stock.
Ratings data for HUM provided by MarketBeat
Humana (NYSE:HUM) was given a new $345.00 price target on by analysts at Mizuho. They now have an "outperform" rating on the stock.
Ratings data for HUM provided by MarketBeat
Humana (NYSE:HUM) had its price target raised by analysts at Wolfe Research from $283.00 to $313.00. They now have an "outperform" rating on the stock.
Ratings data for HUM provided by MarketBeat
Humana (NYSE:HUM) had its price target lowered by analysts at Wolfe Research from $313.00 to $300.00. They now have an "outperform" rating on the stock.
Ratings data for HUM provided by MarketBeat
Humana (NYSE:HUM) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $235.00 to $215.00. They now have a "sell" rating on the stock.
Ratings data for HUM provided by MarketBeat
Humana (NYSE:HUM) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.
Ratings data for HUM provided by MarketBeat
Humana (NYSE:HUM) had its price target lowered by analysts at Jefferies Financial Group Inc. from $313.00 to $310.00. They now have a "buy" rating on the stock.
Ratings data for HUM provided by MarketBeat
Humana (NYSE:HUM) had its price target lowered by analysts at Jefferies Financial Group Inc. from $310.00 to $235.00. They now have a "buy" rating on the stock.
Ratings data for HUM provided by MarketBeat
Humana (NYSE:HUM) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $215.00 to $158.00. They now have a "sell" rating on the stock.
Ratings data for HUM provided by MarketBeat
Humana (NYSE:HUM) had its price target lowered by analysts at Raymond James Financial, Inc. from $340.00 to $230.00. They now have an "outperform" rating on the stock.
Ratings data for HUM provided by MarketBeat
Humana (HUM) had its price target lowered by Wolfe Research from $325.00 to $250.00. They now have an "outperform" rating on the stock.
Ratings data for HUM provided by MarketBeat
Humana (HUM) had its "buy" rating reaffirmed by Guggenheim. They now have a $269.00 price target on the stock.
Ratings data for HUM provided by MarketBeat
Humana (HUM) had its "outperform" rating reaffirmed by Oppenheimer Holdings, Inc..
Ratings data for HUM provided by MarketBeat
Humana (HUM) had its "outperform" rating reaffirmed by Raymond James Financial, Inc..
Ratings data for HUM provided by MarketBeat
Humana (HUM) had its price target raised by The Goldman Sachs Group, Inc. from $158.00 to $195.00. They now have a "sell" rating on the stock.
Ratings data for HUM provided by MarketBeat
Neueste Beiträge
BNP_Paribas_Exane in General Dynamics Corp. diskutieren